Paying users zone. Data is hidden behind hidden.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Verified by Visa MasterCard SecureCode American Express SafeKey

This is a one-time payment. There is no automatic renewal.

Microsoft Excel LibreOffice Calc

Pfizer Inc. (PFE)


Income Statement

Low level of difficulty

Pfizer Inc., consolidated income statement

US$ in millions

Microsoft Excel LibreOffice Calc
12 months ended Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Revenues hidden hidden hidden hidden hidden
Cost of sales hidden hidden hidden hidden hidden
Gross profit hidden hidden hidden hidden hidden
Selling, informational and administrative expenses hidden hidden hidden hidden hidden
Research and development expenses hidden hidden hidden hidden hidden
Amortization of intangible assets hidden hidden hidden hidden hidden
Restructuring charges and certain acquisition-related costs hidden hidden hidden hidden hidden
Operating income hidden hidden hidden hidden hidden
Interest income hidden hidden hidden hidden hidden
Interest expense hidden hidden hidden hidden hidden
Net interest expense hidden hidden hidden hidden hidden
Foreign currency loss related to Venezuela hidden hidden hidden hidden hidden
Royalty-related income hidden hidden hidden hidden hidden
Net gains on asset disposals hidden hidden hidden hidden hidden
Net gains recognized during the period on investments in equity securities hidden hidden hidden hidden hidden
Net realized losses on sales of investments in debt securities hidden hidden hidden hidden hidden
Income from collaborations, out-licensing arrangements and sales of compound/product rights hidden hidden hidden hidden hidden
Net periodic benefit credits other than service costs hidden hidden hidden hidden hidden
Certain legal matters, net hidden hidden hidden hidden hidden
Certain asset impairments hidden hidden hidden hidden hidden
Loss on sale and impairment on remeasurement of HIS net assets hidden hidden hidden hidden hidden
Business and legal entity alignment costs hidden hidden hidden hidden hidden
Net losses on early retirement of debt hidden hidden hidden hidden hidden
Other, net hidden hidden hidden hidden hidden
Other income (deductions), net hidden hidden hidden hidden hidden
Income from continuing operations before (provision) benefit for taxes on income hidden hidden hidden hidden hidden
(Provision) benefit for taxes on income hidden hidden hidden hidden hidden
Income from continuing operations hidden hidden hidden hidden hidden
Income (loss) from discontinued operations, net of tax hidden hidden hidden hidden hidden
Gain (loss) on disposal of discontinued operations, net of tax hidden hidden hidden hidden hidden
Discontinued operations, net of tax hidden hidden hidden hidden hidden
Net income before allocation to noncontrolling interests hidden hidden hidden hidden hidden
Net income attributable to noncontrolling interests hidden hidden hidden hidden hidden
Net income attributable to Pfizer Inc. hidden hidden hidden hidden hidden
Preferred stock dividends, net of tax hidden hidden hidden hidden hidden
Net income attributable to Pfizer Inc. common shareholders hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-28), 10-K (filing date: 2018-02-22), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-29), 10-K (filing date: 2015-02-27).

Income statement item Description The company
Revenues Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. Pfizer Inc.’s revenues declined from 2016 to 2017 but then increased from 2017 to 2018 exceeding 2016 level.
Operating income The net result for the period of deducting operating expenses from operating revenues. Pfizer Inc.’s operating income increased from 2016 to 2017 and from 2017 to 2018.
Income from continuing operations before (provision) benefit for taxes on income Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Pfizer Inc.’s income from continuing operations before (provision) benefit for taxes on income increased from 2016 to 2017 but then slightly declined from 2017 to 2018.
Net income attributable to Pfizer Inc. The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Pfizer Inc.’s net income attributable to Pfizer Inc. increased from 2016 to 2017 but then slightly declined from 2017 to 2018 not reaching 2016 level.